Protons 101

Pelvis or No Pelvis? That is the question.

A Classic Prostate Cancer Debate Resurfaces. Can RTOG 0924 build a consensus?

Nov 9 • 

Mark Storey MD

6

October 2025

A breast cancer story: Butterflies

Butterflies...

Oct 26 • 

Mark Storey MD

5

2

1

Head Neck Cancer: TORPEdO dropped! IMRT vs. Protons, Round 2.

Now two trials with different conclusions?? What can we learn?

Oct 12 • 

Mark Storey MD

2

1

September 2025

Head and Neck Cancer: Approach and Modality are creating variance.

Progress can be a double edged sword. An example of a 70% reduction in dose.

Sep 7 • 

Mark Storey MD

1

1

August 2025

New Radiation Cancer Facility Opens. Radiation Oncology throws stones.

What's worse than the Death Star of medicine? A carbon ion Death Star. At least if you listen to our own field.

Aug 17 • 

Mark Storey MD

8

10

1

July 2025

Technology or Margins?

Where do you land? A thought piece on what might lie ahead for our field.

Jul 13 • 

Mark Storey MD

4

3

2

June 2025

Head and Neck Cancer: Overall Survival Benefit with Protons...?

Updates from PTCOG in Argentina. An initial look at the randomized prospective data.

Jun 22 • 

Mark Storey MD

4

2

PSA Screening: Data Speaks Loudly

Recommendations changed in 2012 and outcomes immediately worsened. What the data shows and how we can do better.

Jun 8 • 

Mark Storey MD

6

9

5

May 2025

IMRT De-escalation vs: Protons

How should we consider these two approaches?

May 18 • 

Mark Storey MD

5

2

1

Head and Neck Cancer: Elective Nodal De-Escalation

A New Era in elective nodal dosing is replacing a 60+ year standard.

May 4 • 

Mark Storey MD

11

2

2

May 2024

Protons vs. Photons: Esophageal Cancer

In Part 2 of this series, we'll look at the data for esophageal cancer

May 12, 2024 • 

Mark Storey MD

1

Protons vs. Photons: Lung Cancer

A look at data for where toxicities might differ between the two modalities

May 5, 2024 • 

Mark Storey MD

2

2